Clinical Trial Update: A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Cadonilimab Injection and Temozolomide in Second-line and Subsequent Treatment of Advanced Melanoma [NA]

View source ↗

Summary

A single-arm multicenter clinical trial evaluating the combination of Fruquintinib, Cadonilimab, and Temozolomide in second-line and later advanced melanoma; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Cadonilimab
• Fruquintinib (fruquintinib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Fudan University | Conditions: Malignant Melanoma | NA | Status: NOT_YET_RECRUITING